The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia
Mutations in the calcium-binding protein calsequestrin cause the highly lethal familial arrhythmia catecholaminergic polymorphic ventricular tachycardia (CPVT). In vivo, calsequestrin multimerizes into filaments, but there is not yet an atomic-resolution structure of a calsequestrin filament. We rep...
Saved in:
Published in | Nature structural & molecular biology Vol. 27; no. 12; pp. 1142 - 1151 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.12.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1545-9993 1545-9985 1545-9985 |
DOI | 10.1038/s41594-020-0510-9 |
Cover
Summary: | Mutations in the calcium-binding protein calsequestrin cause the highly lethal familial arrhythmia catecholaminergic polymorphic ventricular tachycardia (CPVT). In vivo, calsequestrin multimerizes into filaments, but there is not yet an atomic-resolution structure of a calsequestrin filament. We report a crystal structure of a human cardiac calsequestrin filament with supporting mutational analysis and in vitro filamentation assays. We identify and characterize a new disease-associated calsequestrin mutation, S173I, that is located at the filament-forming interface, and further show that a previously reported dominant disease mutation, K180R, maps to the same surface. Both mutations disrupt filamentation, suggesting that disease pathology is due to defects in multimer formation. An ytterbium-derivatized structure pinpoints multiple credible calcium sites at filament-forming interfaces, explaining the atomic basis of calsequestrin filamentation in the presence of calcium. Our study thus provides a unifying molecular mechanism through which dominant-acting calsequestrin mutations provoke lethal arrhythmias.
A new X-ray crystal structure and supporting biochemical analyses of the human cardiac calsequestrin polymer reveal the basis of filament assembly and map disease-associated mutations to the multimerization interface. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author Contributions R.C.D. and E.W.T conceived and designed the study. R.C.D., N.J., and E.W.T. designed and oversaw experiments. E.W.T., F.H.D., and C.S. performed experiments. M.S. and J.W. collected and analyzed clinical data. E.W.T. analyzed experimental data. E.W.T. wrote the manuscript. M.S., J.W., N.J., and R.C.D. reviewed and edited the manuscript. |
ISSN: | 1545-9993 1545-9985 1545-9985 |
DOI: | 10.1038/s41594-020-0510-9 |